Literature DB >> 19959201

Phosphodiesterase type V inhibitors: Occurrence and fate in wastewater and sewage sludge.

Antonio Nieto1, Manuela Peschka, Francesc Borrull, Eva Pocurull, Rosa Maria Marcé, Thomas P Knepper.   

Abstract

The contamination of wastewater and sewage sludge has been examined for three phosphodiesterase type V inhibitors sildenafil, vardenafil and tadalafil, active agents of Viagra, Levitra and Cialis, respectively. Sensitive quantification methods based on solid-phase extraction (SPE) and pressurized liquid extraction (PLE) followed by high performance liquid chromatography - tandem mass spectrometry (HPLC-MS/MS) have been developed to analyse these compounds in wastewater and sewage sludge. Effluent water of nine sewage treatment plants (STPs) has been analysed to assess the impact of the phosphodiesterase type V inhibitors on the environment. One municipal STP (Tarragona, Spain) has been thoroughly studied over the year 2008 (i) with respect to the distribution of these compounds among influent and sewage sludge and (ii) the elimination efficiency. The developed methods allowed quantification at trace concentrations. Sildenafil was present in all investigated samples at the low ng/L and ng/g range, respectively. Tadalafil was not detected or below the limit of detection (LOQ) in effluent water taken in Spain but in sewage sludge (12 ng/g - < LOQ). Vardenafil was present only in one sludge sample and between 5 ng/g and < LOQ in effluent water. The overall removal efficiency of the STP in Tarragona (Spain) is 68%, 69% and 80% for sildenafil, tadalafil and vardenafil, respectively. This study shows for the first time the determination of these compounds in wastewater and sewage sludge. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959201     DOI: 10.1016/j.watres.2009.11.009

Source DB:  PubMed          Journal:  Water Res        ISSN: 0043-1354            Impact factor:   11.236


  3 in total

1.  Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.

Authors:  M Rosa Boleda; Elida Alechaga; Encarnación Moyano; M Teresa Galceran; Francesc Ventura
Journal:  Environ Sci Pollut Res Int       Date:  2014-04-24       Impact factor: 4.223

2.  Prioritizing environmental risk of prescription pharmaceuticals.

Authors:  Zhao Dong; David B Senn; Rebecca E Moran; James P Shine
Journal:  Regul Toxicol Pharmacol       Date:  2012-07-17       Impact factor: 3.271

Review 3.  Distribution and Chemical Analysis of Pharmaceuticals and Personal Care Products (PPCPs) in the Environmental Systems: A Review.

Authors:  C R Ohoro; A O Adeniji; A I Okoh; And O O Okoh
Journal:  Int J Environ Res Public Health       Date:  2019-08-21       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.